title: Triglyceride-rich lipoprotein abnormalities in CAPD-treated patients.
abstract: In the present study intermediate-density lipoproteins (IDL) and very-low-density lipoproteins (VLDL) composition, structure, and mass were analysed in fasting uraemic patients on continuous ambulatory peritoneal dialysis (CAPD) (n = 12) and on haemodialysis (HD) (n = 15), and in 15 healthy volunteers. All the groups were matched for sex, age, and time on dialysis. Both groups of patients had elevated very-low-density lipoprotein levels, CAPD patients four and HD group three times that of control. We found a fourfold and a twofold increase in the concentration of IDL cholesterol in the CAPD and HD group respectively when they were compared with the control group. Both groups of patients present an increased VLDL mass. The CAPD group showed a four-fold increase in IDL mass compared with the control group, which indicated a preponderance of large size and suggested that defective IDL clearance was involved. The IDL composition of the CAPD patients was significantly different from that of the HD patients: a twofold increase in IDL mass was observed in the CAPD patients if compared with HD patients. We report new data concerning the metabolism of triglyceride-rich lipoproteins in CAPD treated patients, which confirm the adverse effect of CAPD on serum lipids.
authors.affiliation: Clinical Chemistry Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
authors.forename: R
authors.initials: R
authors.lastname: Llopart
authors.forename: T
authors.initials: T
authors.lastname: Doñate
authors.forename: J A
authors.initials: JA
authors.lastname: Oliva
authors.forename: M
authors.initials: M
authors.lastname: Rodá
authors.forename: F
authors.initials: F
authors.lastname: Rousaud
authors.forename: F
authors.initials: F
authors.lastname: Gonzalez-Sastre
authors.forename: J
authors.initials: J
authors.lastname: Pedreño
authors.forename: J
authors.initials: J
authors.lastname: Ordoñez-Llanos
mesh_terms: D000328:Adult; D000368:Aged; D002784:Cholesterol / Q000097:blood; D005260:Female; D006801:Humans; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010743:Phospholipids / Q000097:blood; D006435:Renal Dialysis / Q000009:adverse effects; D014280:Triglycerides / Q000097:blood*; D014511:Uremia / Q000097:blood* / Q000628:therapy
chemical_list: D008074:Lipoproteins; D010743:Phospholipids; D014280:Triglycerides; D002784:Cholesterol